Solid Organ Transplant

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/14

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 7:26 PM on 7/26/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

15 Terms

1
New cards

immunosuppression protocol

Calcineurin inhibitor + Antiproliferative + Steroid

2
New cards

Calcineurin inhibitor

Inhibit transcription of cytokines, mainly IL-2, that regulate activity of T-lymphocytes

3
New cards

tacro ade

neurotoxicity, hair loss, HTN, HLD, electrolyte abnormality, nephrotoxicity, new-onset diabetes

4
New cards

cyclosporine ade

neurotoxicity, hirsutism, HTN, HLD, electrolyte abnormalities, nephrotoxicity, new-onset diabetes/hyperglycemia

5
New cards

Increase CNI conc

azole antifungals, calcium channel blockers, macrolide antibiotics, protease inhibitors, grapefruit and Seville oranges

6
New cards

decrease CNI concentrations

rifampin, anti epileptics: carbamazepine, phenobarbital, phenytooin

7
New cards

Cellcept ade

leukopenia

GI disturbance

8
New cards

cellcept BBW

birth defects or 1st trimester pregnancy loss

May reduce concentration of hormonal contraception

9
New cards

superior

mycophenolate mode til is the primary antiproliferative agent used in transplant and has been shown to be superior to azathioprine in prevention of acute rejection

No nephrotoxicity or adverse effects on lipids and glucose levels

10
New cards

azathioprine

first antiproliferative used for SOT but use has declined since introduction of cellcept

Metabolized by xanthine oxidase and thiopurine methyltransferase

may be good option for patients unable to tolerate mycophenolate due to GI side effects or women wanting to become pregnant

11
New cards

mTOR inhibitors

can be used instead of CNI for patients that have ADE or have recurrent skin cancers - sometimes used in combo with low dose CNIs

Bind to regulatory kinases (FKB12) which inhibits mTORC1 and blocks response to IL2 mediated tcell proliferation

12
New cards

everolimus ade

Zortress - delayed wound healing, inc TG, HLD, leukopenia, mouth sores, peripheral edema

13
New cards

sirolimus ade

delayed wound healing, inc TG, HLD, leukopenia, mouth sores,peripheral edema

14
New cards

Co-stimulation blocker and fusion inhibitor

belatacept (Nulojix)

Prevent activation of T cells and promote cell apoptosis - often used instead CNII sparing immunosuppressant regimens

15
New cards

nulojix ade

anemia, leukopenia, peripheral edema, headache, GI disturbance